These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 30695310

  • 1. [Biorisk Management for Clinical Diagnostic Laboratories].
    Shigematsu M.
    Rinsho Byori; 2016 Nov; 64(11):1279-1289. PubMed ID: 30695310
    [Abstract] [Full Text] [Related]

  • 2. A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan.
    Muhammad J, Sarwar S, Khan T, Qasmi SA, Ikram A, Ahmad G, Zahid M, Durrani RH, Ahmed F.
    Front Public Health; 2021 Nov; 9():766162. PubMed ID: 34976925
    [Abstract] [Full Text] [Related]

  • 3. Strengthening Biorisk Management Capacities in Burkina Faso: Contribution of the Global Health Security Agenda.
    Dama E, Orelle A, Nikiema A, Mandingar PD, Naby A, Bationo GB, Kéita MS, Pierson A, Sawadogo C, Koné RG.
    Health Secur; 2022 Nov; 20(6):479-487. PubMed ID: 36399610
    [Abstract] [Full Text] [Related]

  • 4. [Biosafety provision on handling pathogenic biological agents on the concept of biorisk assessment and management].
    Dobrokhotskiĭ ON, Kolombet LV.
    Gig Sanit; 2010 Nov; (5):79-81. PubMed ID: 21344700
    [Abstract] [Full Text] [Related]

  • 5. Strengthening Biorisk Management in Research Laboratories with Security-Sensitive Biological Agents Like SARS-CoV-2.
    Phyu S, Joseph T, Goulart M.
    Methods Mol Biol; 2022 Nov; 2452():395-439. PubMed ID: 35554919
    [Abstract] [Full Text] [Related]

  • 6. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
    Zaki AN.
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
    [Abstract] [Full Text] [Related]

  • 7. Challenges in Implementing a Biorisk Management Program at Universitas Indonesia: A Checklist Tool for Biorisk Management.
    Naroeni A, Bachtiar EW, Ibrahim F, Bela B, Kusminanti Y, Pujiriani I, Lestari F.
    Health Secur; 2016 Nov; 14(6):375-381. PubMed ID: 27830940
    [Abstract] [Full Text] [Related]

  • 8. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
    Appelt S, Jacob D, Rohleder AM, Bråve A, Szekely Björndal Å, Di Caro A, Grunow R, Joint Action EMERGE laboratory networkThe EMERGE partners are acknowledged at the end of the article..
    Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of international virtual training on biorisk management in the context of COVID-19.
    Qasmi SA, Standley C, Mohsin S, Sarwar S, Malik L, Aziz F.
    Front Public Health; 2022 Sep; 10():888097. PubMed ID: 36339241
    [Abstract] [Full Text] [Related]

  • 10. Harmonization of European laboratory response networks by implementing CWA 15793: use of a gap analysis and an "insider" exercise as tools.
    Sundqvist B, Bengtsson UA, Wisselink HJ, Peeters BP, van Rotterdam B, Kampert E, Bereczky S, Johan Olsson NG, Szekely Björndal A, Zini S, Allix S, Knutsson R.
    Biosecur Bioterror; 2013 Sep; 11 Suppl 1():S36-44. PubMed ID: 23971820
    [Abstract] [Full Text] [Related]

  • 11. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.
    Joseph T, Phyu S, Se-Thoe SY, Chu JJH.
    Methods Mol Biol; 2022 Sep; 2452():441-464. PubMed ID: 35554920
    [Abstract] [Full Text] [Related]

  • 12. A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring.
    Orelle A, Nikiema A, Zakaryan A, Albetkova AA, Keita MS, Rayfield MA, Peruski LF, Pierson A.
    Health Secur; 2022 Sep; 20(6):488-496. PubMed ID: 36383124
    [Abstract] [Full Text] [Related]

  • 13. WHO Laboratory Biosafety Manual: A New Approach to Security.
    Ficociello B, Giordano D, Incoronato F, Farinella A, Pietrangeli B.
    Ann Work Expo Health; 2023 Apr 21; 67(4):425-429. PubMed ID: 36495279
    [Abstract] [Full Text] [Related]

  • 14. Concepts to Bolster Biorisk Management.
    Dettmann RA, Ritterson R, Lauer E, Casagrande R.
    Health Secur; 2022 Apr 21; 20(5):376-386. PubMed ID: 35997589
    [Abstract] [Full Text] [Related]

  • 15. Certification & validation of biosafety level-2 & biosafety level-3 laboratories in Indian settings & common issues.
    Mourya DT, Yadav PD, Khare A, Khan AH.
    Indian J Med Res; 2017 Oct 21; 146(4):459-467. PubMed ID: 29434059
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessment of biosafety implementation in clinical diagnostic laboratories in Pakistan during the COVID-19 pandemic.
    Sarwar S, Shahzad F, Vajeeha A, Munir R, Yaqoob A, Naeem A, Sattar M, Gull S.
    J Biosaf Biosecur; 2022 Jun 21; 4(1):43-49. PubMed ID: 35072000
    [Abstract] [Full Text] [Related]

  • 18. Assessment of the Biosafety and Biosecurity Landscape in the Philippines and the Development of the National Biorisk Management Framework.
    Destura RV, Lam HY, Navarro RC, Lopez JCF, Sales RKP, Gomez MIFA, Dela Tonga A, Ulanday GE.
    Appl Biosaf; 2021 Dec 01; 26(4):232-244. PubMed ID: 36034094
    [Abstract] [Full Text] [Related]

  • 19. Highlights of Biosafety and Biosecurity Month (BBM)at the AIMST University and Perspectives on Biorisk Management.
    Bhore SJ.
    Bioinformation; 2019 Dec 01; 15(8):568-571. PubMed ID: 31719766
    [Abstract] [Full Text] [Related]

  • 20. Understanding Biosafety and Biosecurity in Ukraine.
    Houser RS, Koblentz GD, Lentzos F.
    Health Secur; 2023 Dec 01; 21(1):70-80. PubMed ID: 36629857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.